R
Robert M. Merion
Researcher at University of Michigan
Publications - 301
Citations - 28862
Robert M. Merion is an academic researcher from University of Michigan. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 81, co-authored 297 publications receiving 26529 citations. Previous affiliations of Robert M. Merion include Eli Lilly and Company & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study
Benjamin Samstein,Abigail R. Smith,Chris E. Freise,Michael A. Zimmerman,Talia Baker,Kim M. Olthoff,Robert A. Fisher,Robert M. Merion +7 more
TL;DR: Complications occurring with higher probability in LDLT included biliary‐related complications and hepatic artery thrombosis, while in DDLT, ascites, intra‐abdominal bleeding, cardiac complications and pulmonary edema were significantly more probable.
Journal ArticleDOI
Innovations in the Assessment of Transplant Center Performance: Implications for Quality Improvement
David A. Axelrod,John D. Kalbfleisch,R. J. Sun,Mary K. Guidinger,Pinaki Biswas,G. N. Levine,C. J. Arrington,Robert M. Merion +7 more
TL;DR: When retrospectively compared to currently available data reporting, the CUSUM method was found to detect clinically significant changes in center performance more rapidly, which has the potential to inform center leadership and enhance quality improvement efforts.
Journal ArticleDOI
The Riskiest Job in Medicine: Transplant Surgeons and Organ Procurement Travel
TL;DR: Though these data have important limitations, they suggest that organ procurement travel is associated with significant risk and improvements in organ procurementTravel are needed.
Journal ArticleDOI
Effect of pretransplant serum creatinine on the survival benefit of liver transplantation
TL;DR: It is concluded that serum creatinine at LT significantly affects survival benefit for patients with MELD scores of 15 to 17 or 24 to 40, and the relative ranking of a large number of wait‐listed candidates with M Eld score would be markedly affected if these findings were incorporated into the allocation policy.